Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

PTC Therapeutics (NASDAQ:PTCT) Director Sells 10,000 Shares

Summary by MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) Director Michael Schmertzler sold 10,000 shares of the firm's stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $67.12, for a total value of $671,200.00. Following the transaction, the director directly owned 1,306,594 shares of the company's stock, valued at $87,698,589.28. This represents a 0.76% decrease in their position. The sale was disclo…

1 Articles

MarketBeatMarketBeat
Center

PTC Therapeutics (NASDAQ:PTCT) Director Sells 10,000 Shares

PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) Director Michael Schmertzler sold 10,000 shares of the firm's stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $67.12, for a total value of $671,200.00. Following the transaction, the director directly owned 1,306,594 shares of the company's stock, valued at $87,698,589.28. This represents a 0.76% decrease in their position. The sale was disclo…

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Friday, September 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

South Plainfield icon

South Plainfield

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal